Filtros de búsqueda

Lista de obras de Hans Lilja

A common prostate cancer risk variant 5' of microseminoprotein-beta (MSMB) is a strong predictor of circulating beta-microseminoprotein (MSP) levels in multiple populations ⬇️

artículo científico publicado el 24 de agosto de 2010

A comprehensive nomenclature for serine proteases with homology to tissue kallikreins

artículo científico publicado en 2006

A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer screening in Rotterdam, Netherlands.

artículo científico publicado en 2010

A four-kallikrein panel predicts prostate cancer in men with recent screening: data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam

artículo científico publicado en 2010

A highly conserved protein secreted by the prostate cancer cell line PC-3 is expressed in benign and malignant prostate tissue

artículo científico publicado en 2007

A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein

artículo científico publicado en 1985

A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein

artículo científico publicado en 2002

A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan Index.

artículo científico publicado en 2012

A panel of kallikrein marker predicts prostate cancer in a large, population-based cohort followed for 15 years without screening

artículo científico publicado en 2010

A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France

artículo científico publicado en 2010

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

artículo científico publicado en 2008

Acoustic whole blood plasmapheresis chip for prostate specific antigen microarray diagnostics

artículo científico publicado en 2009

Activation of latent protease function of pro-hK2, but not pro-PSA, involves autoprocessing

artículo científico publicado en 2001

Alteration of the hormonal bioactivity of parathyroid hormone-related protein (PTHrP) as a result of limited proteolysis by prostate-specific antigen

artículo científico publicado en 1996

Aminopeptidase activities as prospective urinary biomarkers for bladder cancer

artículo científico publicado en 2014

An autocrine loop for vascular endothelial growth factor is established in prostate cancer cells generated after prolonged treatment with interleukin 6.

artículo científico publicado en 2004

An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection

artículo científico publicado en 2011

Analytic and clinical validation of a prostate cancer-enhanced messenger RNA detection assay in whole blood as a prognostic biomarker for survival

artículo científico publicado en 2013

Androgen Deprivation Therapy Potentiates the Efficacy of Vascular Targeted Photodynamic Therapy of Prostate Cancer Xenografts

artículo científico publicado en 2018

Androgen receptor CAG repeat length correlates with semen PSA levels in adolescence

artículo científico publicado en 2004

Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2.

artículo científico publicado en 2002

Assessment of intra-individual variation in prostate-specific antigen levels in a biennial randomized prostate cancer screening program in Sweden

artículo científico publicado en 2005

Association between polymorphisms in the prostate-specific antigen (PSA) promoter and release of PSA

artículo científico publicado en 2008

Association of cancer with moderately impaired renal function at baseline in a large, representative, population-based cohort followed for up to 30 years

artículo científico publicado en 2013

Association of cysteine-rich secretory protein 3 and beta-microseminoprotein with outcome after radical prostatectomy

artículo científico publicado en 2007

Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue

artículo científico publicado en 2005

Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer

artículo científico publicado en 2009

Association of transcript levels of 10 established or candidate-biomarker gene targets with cancerous versus non-cancerous prostate tissue from radical prostatectomy specimens ⬇️

artículo científico publicado el 4 de febrero de 2013

Baseline prostate-specific antigen measurements and subsequent prostate cancer risk in the Danish Diet, Cancer and Health cohort

artículo científico publicado en 2013

Beta-microseminoprotein in serum correlates with the levels in seminal plasma of young, healthy males

artículo científico publicado en 2008

Bioinformatic strategies for unambiguous identification of prostate specific antigen in clinical samples

artículo científico publicado en 2011

Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer

artículo científico publicado en 2010

Blood levels of free-PSA but not complex-PSA significantly correlates to prostate release of PSA in semen in young men, while blood levels of complex-PSA, but not free-PSA increase with age

artículo científico publicado en 2005

Can PSA velocity predict risk of death in men with prostate cancer?

artículo científico publicado en 2007

Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk?

artículo científico publicado en 2013

Cancer-associated changes in the expression of TMPRSS2-ERG, PCA3, and SPINK1 in histologically benign tissue from cancerous vs noncancerous prostatectomy specimens

articulo cientifico

Characterization and processing of prostate specific antigen (hK3) and human glandular kallikrein (hK2) secreted by LNCaP cells

artículo científico publicado en 1999

Characterization of the predominant basic protein in human seminal plasma, one cleavage product of the major seminal vesicle protein

artículo científico publicado en 1984

Chromosome 19 annotations with disease speciation: a first report from the Global Research Consortium.

artículo científico publicado en 2012

Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer

artículo científico publicado en 2007

Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer

scientific article published on 01 December 2007

Circulating biomarkers for prostate cancer

artículo científico publicado en 2007

Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival

artículo científico publicado en 2009

Comparison of Free and Total Forms of Serum Human Kallikrein 2 and Prostate-Specific Antigen for Prediction of Locally Advanced and Recurrent Prostate Cancer

artículo científico publicado en 2006

Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade

artículo científico publicado en 2005

Concurrent isolation of lymphocytes and granulocytes using prefocused free flow acoustophoresis

artículo científico publicado en 2015

Copy number variants in the kallikrein gene cluster

artículo científico publicado en 2013

Cutpoints in clinical chemistry: time for fundamental reassessment

artículo científico publicado en 2008

Defining Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy: A Proposal for a Standardized Definition

scholarly article by Andrew J. Stephenson et al published 20 August 2006 in Journal of Clinical Oncology

Detection of Androgen Receptor Mutations in Circulating Tumor Cells: Highlights of the Long Road to Clinical Qualification ⬇️

artículo científico publicado el 30 de julio de 2010

Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling

artículo científico publicado en 1998

Development of sensitive immunoassays for free and total human glandular kallikrein 2.

artículo científico publicado en 2004

Differential exoprotease activities confer tumor-specific serum peptidome patterns

artículo científico publicado en 2006

Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen

artículo científico publicado en 2002

ENSAM: Europium Nanoparticles for Signal enhancement of Antibody Microarrays on nanoporous silicon

artículo científico publicado en 2008

Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancer

artículo científico publicado en 2009

Editorial Comment

Editorial comment. Association between glomerular filtration rate, free, total, and percent free prostate-specific antigen

artículo científico publicado en 2010

Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3 ⬇️

artículo científico publicado el 3 de agosto de 2010

Emerging PSA-based tests to improve screening

artículo científico publicado en 2014

Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen

artículo científico publicado en 2014

Empirical estimates of the lead time distribution for prostate cancer based on two independent representative cohorts of men not subject to prostate-specific antigen screening

artículo científico publicado en 2010

Enhanced Discrimination of Benign from Malignant Prostatic Disease by Selective Measurements of Cleaved Forms of Urokinase Receptor in Serum

artículo científico publicado en 2006

Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.

artículo científico publicado en 2011

Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.

artículo científico publicado en 2012

Evaluation of a new immunoassay for cystatin C, based on a double monoclonal principle, in men with normal and impaired renal function ⬇️

artículo científico publicado el 15 de junio de 2011

Evaluation of molecular forms of prostate-specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy

scientific article published on February 2009

Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.

artículo científico publicado en 2011

Evaluation of prediagnostic prostate-specific antigen dynamics as predictors of death from prostate cancer in patients treated conservatively

artículo científico publicado en 2011

Exogenous protein kinases A and C, but not endogenous prostasome-associated protein kinase, phosphorylate semenogelins I and II from human semen

artículo científico publicado en 2002

Expression and immunolocalisation of neutral endopeptidase in prostate cancer.

artículo científico publicado en 2003

Expression of prostate specific antigen on the surface of a filamentous phage.

artículo científico

Expression of prostate-specific antigen (PSA) and human glandular kallikrein 2 (hK2) in ileum and other extraprostatic tissues

artículo científico publicado en 2005

Expression of protein C inhibitor (PCI) in benign and malignant prostatic tissues

artículo científico publicado en 2003

Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer

artículo científico publicado en 2018

Finasteride to prevent prostate cancer: should all men or only a high-risk subgroup be treated?

artículo científico publicado en 2010

Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer

artículo científico publicado en 2009

Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy

scholarly article by Thomas Steuber et al published 4 January 2007 in International Journal of Cancer

Free, complexed and total serum prostate-specific antigen concentrations and their proportions in predicting stage, grade and deoxyribonucleic acid ploidy in patients with adenocarcinoma of the prostate

artículo científico publicado en 1996

Free‐to‐total prostate‐specific antigen ratio as a predictor of non‐organ‐confined prostate cancer (stage pT3)

artículo científico publicado en 2003

Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapy

artículo científico publicado en 2020

Genetic variation in KLK2 and KLK3 is associated with concentrations of hK2 and PSA in serum and seminal plasma in young men

artículo científico publicado en 2013

Genome-wide association study identifies novel single nucleotide polymorphisms having age-specific effect on prostate-specific antigen levels

scientific article published on 11 September 2020

High-speed biomarker identification utilizing porous silicon nanovial arrays and MALDI-TOF mass spectrometry

artículo científico publicado en 2006

Identification of a novel proteoform of prostate specific antigen (SNP-L132I) in clinical samples by multiple reaction monitoring

artículo científico publicado en 2013

Identification of prostate-specific antigen (PSA) isoforms in complex biological samples utilizing complementary platforms

artículo científico publicado en 2010

Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen.

artículo científico publicado en 2012

Immunoassay for the discrimination of free prostate-specific antigen (fPSA) forms with internal cleavages at Lys145 or Lys146 from fPSA without internal cleavages at Lys145 or Lys146 ⬇️

artículo científico publicado el 28 de abril de 2011

Immunohistochemical detection of cysteine-rich secretory protein 3 in tissue and in serum from men with cancer or benign enlargement of the prostate gland

artículo científico publicado en 2006

Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden

artículo científico publicado en 2010

Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group.

artículo científico publicado en 2011

Improved porous silicon microarray based prostate specific antigen immunoassay by optimized surface density of the capture antibody

artículo científico publicado en 2013

In Reply

Increase in percent free prostate-specific antigen in men with chronic kidney disease

artículo científico publicado en 2008

Individualized screening interval for prostate cancer based on prostate-specific antigen level: results of a prospective, randomized, population-based study

artículo científico publicado en 2005

Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen

artículo científico publicado en 2003

Innovations in serum and urine markers in prostate cancer current European research in the P-Mark project.

artículo científico publicado en 2005

Intact free prostate-specific antigen and free and total human glandular kallikrein 2. Elimination of assay interference by enzymatic digestion of antibodies to F(ab')2 fragments

artículo científico publicado en 2006

Integrated acoustic immunoaffinity-capture (IAI) platform for detection of PSA from whole blood samples

artículo científico publicado en 2013

Integrated selective enrichment target--a microtechnology platform for matrix-assisted laser desorption/ionization-mass spectrometry applied on protein biomarkers in prostate diseases

artículo científico publicado en 2004

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

artículo científico publicado en 2019

Intra-individual short-term variability of prostate-specific antigen and other kallikrein markers in a serial collection of blood from men under evaluation for prostate cancer

artículo científico publicado en 2010

Isoformen des freien prostataspezifischen Antigens

artículo científico publicado en 2004

It ain't what you do, it's the way you do it: five golden rules for transforming prostate-specific antigen screening

Kallikrein markers performance in pretreatment blood to predict early prostate cancer recurrence and metastasis after radical prostatectomy among very high-risk men

artículo científico publicado en 2019

Lead time associated with screening for prostate cancer.

artículo científico publicado en 2004

Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations

artículo científico publicado en 2012

Liquefaction of coagulated human semen

artículo científico publicado en 1984

Long-Term Prediction of Prostate Cancer: Prostate-Specific Antigen (PSA) Velocity Is Predictive but Does Not Improve the Predictive Accuracy of a Single PSA Measurement 15 Years or More Before Cancer Diagnosis in a Large, Representative, Unscreened P

artículo científico publicado en 2008

Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.

artículo científico

MALDI-target integrated platform for affinity-captured protein digestion

artículo científico publicado en 2013

Measurements of Proteases or Protease System Components in Blood to Enhance Prediction of Disease Risk or Outcome in Possible Cancer

Microchannel acoustophoresis does not impact survival or function of microglia, leukocytes or tumor cells

artículo científico publicado en 2013

Microfluidic, label-free enrichment of prostate cancer cells in blood based on acoustophoresis

artículo científico publicado en 2012

Molecular insights into substrate specificity of prostate specific antigen through structural modeling

artículo científico publicado en 2009

Molecular microheterogeneity of prostate specific antigen in seminal fluid by mass spectrometry

artículo científico publicado en 2011

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

artículo científico publicado en 2010

NADiA ProsVue prostate-specific antigen slope is an independent prognostic marker for identifying men at reduced risk of clinical recurrence of prostate cancer after radical prostatectomy

artículo científico publicado en 2012

NF-kappaB regulates androgen receptor expression and prostate cancer growth

scientific article published on 23 July 2009

National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers

artículo científico publicado en 2008

Needle Biopsies on Autopsy Prostates: Sensitivity of Cancer Detection Based on True Prevalence

scientific article published on 25 September 2007

Novel homogenous time-resolved fluorometric RT-PCR assays for quantification of PSA and hK2 mRNAs in blood

artículo científico publicado en 2006

On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer

artículo científico publicado en 2010

PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section

artículo científico publicado en 2007

PSA is Dead, Long Live PSA

article by Andrew J Vickers & Hans Lilja published March 2012 in European Urology

PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates

artículo científico publicado en 2021

Pharmacokinetics, biodistribution, and antitumor efficacy of a human glandular kallikrein 2 (hK2)-activated thapsigargin prodrug

artículo científico publicado en 2006

Polymorphisms at the Microseminoprotein-beta locus associated with physiologic variation in beta-microseminoprotein and prostate-specific antigen levels

artículo científico publicado en 2010

Porous silicon antibody microarrays for quantitative analysis: measurement of free and total PSA in clinical plasma samples

artículo científico publicado en 2012

Predicting high-grade cancer at ten-core prostate biopsy using four kallikrein markers measured in blood in the ProtecT study

artículo científico publicado en 2015

Predicting prostate cancer many years before diagnosis: how and why?

artículo científico publicado en 2011

Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50.

artículo científico publicado en 2010

Predictive value of four kallikrein markers for pathologically insignificant compared with aggressive prostate cancer in radical prostatectomy specimens: results from the European Randomized Study of Screening for Prostate Cancer section Rotterdam.

artículo científico publicado en 2013

Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy

scientific article published on 08 June 2009

Prevention and early detection of prostate cancer

artículo científico publicado en 2014

Properties of the 4-Kallikrein Panel Outside the Diagnostic Gray Zone: Meta-Analysis of Patients with Positive Digital Rectal Examination or Prostate Specific Antigen 10 ng/ml and Above

artículo científico publicado en 2016

Prospective randomized evaluation of risk-adapted prostate-specific antigen screening in young men: the PROBASE trial.

artículo científico publicado en 2013

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized Controlled Trial

artículo científico publicado en 2006

Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

artículo científico publicado en 2009

Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review.

artículo científico publicado en 2012

Prostate cancer: estimating the benefits of PSA screening

artículo científico publicado en 2009

Prostate kallikrein markers in diagnosis, risk stratification and prognosis.

artículo científico publicado en 2009

Prostate specific antigen based biennial screening is sufficient to detect almost all prostate cancers while still curable

artículo científico publicado en 2003

Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.

artículo científico publicado en 2010

Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsy

artículo científico publicado en 2010

Prostate-cancer mortality at 11 years of follow-up

artículo científico publicado en 2012

Prostate-specific antigen (PSA) protein does not affect growth of prostate cancer cells in vitro or prostate cancer xenografts in vivo

artículo científico publicado en 2003

Prostate-specific antigen and prostate cancer: prediction, detection and monitoring.

artículo científico publicado en 2008

Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study

artículo científico publicado en 2008

Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohort

artículo científico publicado en 2009

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

artículo científico publicado en 2018

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

artículo científico publicado en 2018

Prostate-specific kallikrein-related peptidases and their relation to prostate cancer biology and detection. Established relevance and emerging roles

artículo científico publicado en 2013

Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system

artículo científico publicado en 1992

Quantitative PSA RT-PCR for preoperative staging of prostate cancer

artículo científico publicado en 2003

Rapid elimination by glomerular filtration of free prostate specific antigen and human kallikrein 2 after renal transplantation

artículo científico publicado en 2004

Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responses

artículo científico publicado en 2012

Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication

artículo científico publicado en 2010

Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 degrees C.

artículo científico

Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma

artículo científico publicado en 2004

Reverse-phase versus sandwich antibody microarray, technical comparison from a clinical perspective

artículo científico publicado en 2007

Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum

artículo científico publicado en 2006

Risk of dying from prostate cancer in men randomized to screening: differences between attendees and nonattendees

artículo científico publicado en 2009

Screening a combinatorial peptide library to develop a human glandular kallikrein 2-activated prodrug as targeted therapy for prostate cancer.

artículo científico publicado en 2004

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

artículo científico publicado en 2014

Screening and prostate-cancer mortality in a randomized European study

artículo científico publicado en 2009

Screening for Prostate Cancer

Screening for prostate cancer: early detection or overdetection?

artículo científico publicado en 2011

Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen

artículo científico publicado en 1987

Serum markers for prostate cancer: a rational approach to the literature

artículo científico publicado en 2008

Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues

artículo científico publicado en 2001

Simultaneous quantification of human glandular kallikrein 2 and prostate-specific antigen mRNAs in peripheral blood from prostate cancer patients

artículo científico publicado en 2001

Stability of serum prostate-specific antigen determination across laboratory, assay, and storage time

artículo científico publicado en 1995

Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study

artículo científico publicado en 2013

Structural investigation of the alpha-1-antichymotrypsin: prostate-specific antigen complex by comparative model building

artículo científico publicado en 1996

Suitability of quality control materials for prostate-specific antigen (PSA) measurement: inter-method variability of common tumor marker control materials

artículo científico publicado en 2013

Susceptibility loci associated with prostate cancer progression and mortality

artículo científico publicado en 2010

Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer

artículo científico publicado en 2008

Systematic review of statistical methods used in molecular marker studies in cancer

artículo científico publicado en 2008

THE CONTINUING ROLE OF PROSTATE-SPECIFIC ANTIGEN AS A MARKER FOR LOCALIZED PROSTATE CANCER: ‘DO NOT THROW THE BABY OUT WITH THE BATH WATER’

artículo científico publicado en 2009

TMPRSS2-ERG Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate ⬇️

artículo científico publicado el 14 de julio de 2011

Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study

artículo científico publicado en 2014

Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study

artículo científico publicado en 2010

Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone

artículo científico publicado en 2012

Taxon-specific evolution of glandular kallikrein genes and identification of a progenitor of prostate-specific antigen

scientific journal article

Test Sensitivity in the European Prostate Cancer Screening Trial: Results from Finland, Sweden, and the Netherlands

artículo científico publicado en 2009

Testing New PSA Subforms to Enhance the Accuracy of Predicting Cancer Risk and Disease Outcome in Prostate Cancer

artículo científico publicado en 2008

Testing in Serum for Human Glandular Kallikrein 2, and Free and Total Prostate Specific Antigen in Biannual Screening for Prostate Cancer

scientific article published on 01 October 2003

Testosterone as a predictor of pathological stage in clinically localized prostate cancer

artículo científico publicado en 2005

The Four-Kallikrein Panel is Effective in Identifying Aggressive Prostate Cancer in a Multiethnic Population

scientific article published on 08 May 2020

The Proportion of Carboxylated to Total or Intact Osteocalcin in Serum Discriminates Warfarin-Treated Patients from Control Subjects

artículo científico publicado en 1999

The evolution of a genetic locus encoding small serine proteinase inhibitors

artículo científico publicado en 2005

The evolution of the glandular kallikrein locus: identification of orthologs and pseudogenes in the cotton-top tamarin

artículo científico publicado en 2004

The predictive value of prostate cancer biomarkers depends on age and time to diagnosis: towards a biologically-based screening strategy.

artículo científico publicado en 2007

The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group

artículo científico publicado en 2010

The risk of finding focal cancer (less than 3 mm) remains high on re-biopsy of patients with persistently increased prostate specific antigen but the clinical significance is questionable

artículo científico publicado en 2004

The role of SPINK1 in ETS rearrangement-negative prostate cancers

artículo científico publicado en 2008

The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer

scientific article published on 01 February 2003

The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease.

artículo científico publicado en 2001

The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine

artículo científico publicado en 2010

Three genes expressing Kunitz domains in the epididymis are related to genes of WFDC-type protease inhibitors and semen coagulum proteins in spite of lacking similarity between their protein products ⬇️

artículo científico publicado el 11 de octubre de 2011

Time-resolved fluorescence imaging (TRFI) for direct immunofluorescence of PSA and alpha-1-antichymotrypsin in prostatic tissue sections

artículo científico publicado en 1999

Time-resolved fluorescence imaging for quantitative histochemistry using lanthanide chelates in nanoparticles and conjugated to monoclonal antibodies

artículo científico publicado en 2000

Time-resolved fluorometry in end-point and real-time PCR quantification of nucleic acids

artículo científico publicado en 2000

Total and Gleason Grade 4/5 Cancer Volumes are Major Contributors of Human Kallikrein 2, Whereas Free Prostate Specific Antigen is Largely Contributed by Benign Gland Volume in Serum From Patients With Prostate Cancer or Benign Prostatic Biopsies

artículo científico publicado en 2003

Translational crossroads for biomarkers

artículo científico publicado en 2005

Urological cancer: Time for another rethink on prostate cancer screening

artículo científico publicado en 2011

We Need a Better Marker for Prostate Cancer. How About Renaming PSA?

beta-Microseminoprotein binds CRISP-3 in human seminal plasma

artículo científico publicado en 2005

miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients ⬇️

artículo científico publicado el 9 de abril de 2013

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda